The life science industry is all hands on deck in the race to develop vaccines, therapies and diagnostics in the fight against coronavirus. But while some prosper, many in the sector are forced to halt clinical trials and mothball labs
The global pandemic is brutally exposing how reliant the EU – and the rest of the world – is on high quality research, collaboration and data sharing. These lessons must be applied in Horizon Europe
Race to halt the epidemic has prompted intense collaboration among researchers and public health officials worldwide - leaving the blame game to governments
EIT Health is matching hospitals and clinics with advice, computer resources, data tools and equipment. But much of its research is on ice, as all available hands go to fighting the pandemic
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.